Increasing hospitalizations in inflammatory bowel disease among children in the United States, 1988-2011

Inflammatory Bowel Diseases

Volumn 20, Issue 10, 2014, Pages 1754-1760

  Sandberg, Kelly C ^a   Davis, Matthew M ^a,b   Gebremariam, Achamyeleh ^a,b   Adler, Jeremy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Crohn's disease; National trends; Nationwide inpatient sample; Ulcerative colitis; Variance weighted regression

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CHILD HOSPITALIZATION; CROHN DISEASE; CROSS-SECTIONAL STUDY; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; INFLAMMATORY BOWEL DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; ULCERATIVE COLITIS; UNITED STATES; FEMALE; FOLLOW UP; HOSPITALIZATION; INFANT; INFLAMMATORY BOWEL DISEASES; MALE; PROGNOSIS; TIME FACTOR; TRENDS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INFANT; INFLAMMATORY BOWEL DISEASES; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES;

EID: 84925829511     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000195     Document Type: Article

References (58)

1. Markowitz J, Grancher K, Kohn N, et al. Immunomodulatory therapy for pediatric inflammatory bowel disease: changing patterns of use, 1990-2000. Am J Gastroenterol. 2002;97:928-932.
2. Hwang JM, Varma MG. Surgery for inflammatory bowel disease. World J Gastroenterol. 2008;14:2678-2690.
3. Nandivada P, Poylin V, Nagle D. Advances in the surgical management of inflammatory bowel disease. Curr Opin Gastroenterol. 2012;28:47-51.
4. Fichera A, Michelassi F. Surgical treatment of Crohn's disease. J Gastrointest Surg. 2007;11:791-803.
5. Gardiner KR, Dasari BVM. Operative management of small bowel Crohn's disease. Surg Clin North Am. 2007;87:587-610.
6. Leonor R, Jacobson K, Pinsk V, et al. Surgical intervention in children with Crohn's disease. Int J Colorectal Dis. 2007;22:1037-1041.
7. Umanskiy K, Fichera A. Health related quality of life in inflammatory bowel disease: the impact of surgical therapy. World J Gastroenterol. 2010;16:5024-5034.
8. Benchimol EI, Guttmann A, To T, et al. Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994-2007). Inflamm Bowel Dis. 2011;17:2153-2161.
9. Herrinton LJ, Liu L, Fireman B, et al. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Gastroenterology. 2009;137:502-511.
10. AHRQ. Overview of the nationwide inpatient sample. Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed January 19, 2013.
11. Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics. 2004;114:786-792.
12. Patel MS, Gebremariam A, Davis MM. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect Control Hosp Epidemiol. 2008;29:1157-1163.
13. Zickafoose JS, Benneyworth BD, Riebschleger MP, et al. Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States. Arch Pediatr Adolesc Med. 2012;166:350-355.
14. AHRQ. Welcome to HCUPnet. HCUPnet: a tool for identifying, tracking, and analyzing national hospital statistics. Available at: http://hcupnet.ahrq. gov/. Accessed February 5, 2014.
15. Vandenbroucke JP, Von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147:W163-W194.
16. Ananthakrishnan AN, McGinley EL, Binion DG. Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume. Am J Gastroenterol. 2008;103:2789-2798.
17. Nguyen GC, Bayless TM, Powe NR, et al. Race and health insurance are predictors of hospitalized Crohn's disease patients undergoing bowel resection. Inflamm Bowel Dis. 2007;13:1408-1416.
18. Pant C, Anderson MP, Deshpande A, et al. Trends in hospitalizations of children with inflammatory bowel disease within the United States from 2000 to 2009. J Investig Med. 2013;61:1036-1038.
19. AHRQ. Requirements for publishing with HCUP data. Available at: http://www.hcup-us.ahrq.gov/db/publishing.jsp. Accessed January 19, 2013.
20. Ananthakrishnan AN, McGinley EL, Binion DG, et al. A novel risk score to stratify severity of Crohn's disease hospitalizations. Am J Gastroenterol. 2010;105:1799-1807.
21. AHRQ. HCUP on-line tutorial series. Available at: http://www.hcup-us. ahrq.gov/tech-assist/tutorials.jsp. Accessed March 11, 2014.
22. US Census Bureau DID. Population estimates. Available at: http://www.census.gov/popest/data/intercensal/national/nat2010.html. Accessed January 7, 2013.
23. Navaneethan U, Venkatesh PG, Shen B. Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J Gastroenterol. 2010;16:4892-4904.
24. Ananthakrishnan AN, McGinley EL, Saeian K, et al. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:976-983.
25. Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol. 2011;8:17-26.
26. Dumyati G, Stevens V, Hannett GE, et al. Community-associated Clostridium difficile infections, Monroe County, New York, USA. Emerging Infect Dis. 2012;18:392-400.
27. Khanna S, Pardi DS, Aronson SL, et al. The epidemiology of communityacquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012;107:89-95.
28. Patrick SW, Schumacher RE, Benneyworth BD, et al. Neonatal abstinence syndrome and associated health care expenditures United States, 2000-2009. JAMA. 2012;307:1934-1940.
29. Benneyworth BD, Gebremariam A, Clark SJ, et al. Inpatient health care utilization for children dependent on long-term mechanical ventilation. Pediatrics. 2011;127:e1533-e1541.
30. Weisberg S. Applied linear regression. In: Balding DJ, Cressie NAC, Fisher NI, eds. Wiley Series in Probability and Statistics. 3rd ed. Hoboken, NJ: Wiley-Interscience; 2005.
31. Debruyn JCC, Soon IS, Hubbard J, et al. Nationwide temporal trends in incidence of hospitalization and surgical intestinal resection in pediatric inflammatory bowel diseases in the United States from 1997 to 2009. Inflamm Bowel Dis. 2013;19:2423-2432.
32. Hasegawa K, Tsugawa Y, Brown DFM, et al. Childhood asthma hospitalizations in the United States, 2000-2009. J Pediatr. 2013;163:1127. e3-1133.e3.
33. Raphael JL, Mueller BU, Kowalkowski MA, et al. Shorter hospitalization trends among children with sickle cell disease. Pediatr Blood Cancer. 2012. Available at: http://onlinelibrary.wiley.com/doi/10.1002/pbc. 24065/full. Accessed March 13, 2013.
34. Wei CC, Wang W, Smoyer WE, et al. Trends in pediatric primary membranoproliferative glomerulonephritis costs and complications. Pediatr Nephrol. 2012;27:2243-2250.
35. Benchimol EI, Fortinsky KJ, Gozdyra P, et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17:423-439.
36. Malaty HM, Fan X, Opekun AR, et al. Rising incidence of inflammatory bowel disease among children: a 12-year study. J Pediatr Gastroenterol Nutr. 2010;50:27-31.
37. Loftus CG, Loftus EV, Harmsen WS, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis. 2007;13:254-261.
38. Kappelman MD, Moore KR, Allen JK, et al. Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci. 2012;58:519-525.
39. FDA. Infliximab product approval information: licensing action. Available at: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm093327.htm. Accessed June 4, 2013.
40. FDA. FDA approves remicade for children with Crohn's disease. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108656.htm. Accessed June 4, 2013.
41. Shah SS, Hall M, Goodman DM, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161:282-290.
42. Yoon EY, Dombkowski KJ, Rocchini A, et al. Off-label utilization of antihypertensive medications in children. Ambul Pediatr. 2007;7:299-303.
43. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European network for drug investigation in children. BMJ. 2000;320:79-82.
44. Turner S, Longworth A, Nunn AJ, et al. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998;316:343-345.
45. Pandolfini C, Impicciatore P, Provasi D, et al. Off-label use of drugs in Italy: a prospective, observational and multicentre study. Acta Paediatr. 2002;91:339-347.
46. Ramadas AV, Gunesh S, Thomas GAO, et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut. 2010;59:1200-1206.
47. Park SH, Yang SK, Park SK, et al. Long-term prognosis of Crohn's disease and its temporal change between 1981 and 2012: a hospitalbased cohort study from Korea. Inflamm Bowel Dis. 2014;20:488-494.
48. Malafosse M. Crohn's disease: current surgical treatment (article in French). Bull Acad Natl Med. 2007;191:1143-1156, discussion 1157-1158.
49. Pati S, Lorch SA, Lee GE, et al. Health insurance and length of stay for children hospitalized with community-acquired pneumonia. J Hosp Med. 2012;7:304-310.
50. Bekmezian A, Chung PJ, Yazdani S. Staff-only pediatric hospitalist care of patients with medically complex subspecialty conditions in a major teaching hospital. Arch Pediatr Adolesc Med. 2008;162:975-980.
51. Di Guglielmo MD, Plesnick J, Greenspan JS, et al. A new model to decrease time-to-appointment wait for gastroenterology evaluation. Pediatrics. 2013;131:e1632-e1638.
52. Marcin JP, Ellis J, Mawis R, et al. Using telemedicine to provide pediatric subspecialty care to children with special health care needs in an underserved rural community. Pediatrics. 2004;113:1-6.
53. Mattioli L, Goertz K, Ardinger R, et al. Pediatric cardiology: auscultation from 280 miles away. Kans Med. 1992;93:326, 347-350.
54. Mulgrew KW, Shaikh U, Nettiksimmons J. Comparison of parent satisfaction with care for childhood obesity delivered face-to-face and by telemedicine. Telemed J E Health. 2011;17:383-387.
55. Mahnke CB, Jordan CP, Bergvall E, et al. The pacific asynchronous teleHealth (PATH) system: review of 1, 000 pediatric teleconsultations. Telemed J E Health. 2011;17:35-39.
56. Malone F, Callahan CW, Chan DS, et al. Caring for children with asthma through teleconsultation: "ECHO-Pac, the electronic children's hospital of the pacific". Telemed J E Health. 2004;10:138-146.
57. Ananthakrishnan AN, McGinley EL, Binion DG, et al. Simple score to identify colectomy risk in ulcerative colitis hospitalizations. Inflamm Bowel Dis. 2010;16:1532-1540.
58. Kaplan GG. Editorial: administrative database studies in IBD: a cautionary tale. Am J Gastroenterol. 2010;105:1808-1810.